SCHEMBL4928516

SCHEMBL4928516

NC(=O)c1c(-c2ccccc2)nnc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.51
PDE10A Q9Y233 2/20 0.51
LMNA P02545 2/20 0.51
TSHR P16473 1/20 0.50
LCK P06239 1/20 0.50
MAP2K3 P46734 1/20 0.50
MAP2K6 P52564 1/20 0.50
BTK Q06187 1/20 0.50
MAP3K19 Q56UN5 1/20 0.50
NEK10 Q6ZWH5 1/20 0.50
HTT P42858 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
GAA P10253 1/20 0.46
SCN9A Q15858 1/20 0.43
POLB P06746 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2410295 0.86 DHODH (0.63) DHODHPDE10ALMNATSHRHTT
SCHEMBL13971502 0.79 DHODH (0.77) DHODHPDE10ALMNATSHRCYP2D6
SCHEMBL14583114 0.78 PDE10A (0.77) DHODHPDE10ALMNATSHRCYP2D6
SCHEMBL8572508 0.77 LCK (0.54) DHODHPDE10ATSHRLCKMAP2K3
Hydrochloric Acid SCHEMBL6969111 0.76 PDE10A (0.75) DHODHPDE10ALMNATSHRCYP2D6
SCHEMBL61597 0.76 HSD17B10 (0.52) DHODHPDE10ALMNATSHRLCK
SCHEMBL30148539 0.76 HSD17B10 (0.52) DHODHPDE10ALMNATSHRLCK
SCHEMBL2404536 0.74 DHODH (0.52) DHODHPDE10ALMNATSHRCYP2D6
SCHEMBL8271391 0.74 TACR3 (0.65) DHODHPDE10ALMNATSHR
SCHEMBL27921343 0.72 GAA (0.53) LMNAMEN1KMT2AGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090863-A1 Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor MCHR1, GPR119, MCHR2 DHODH 3216/4885PDE10A 1210/4885LMNA 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.